Terkko Navigator / -/ Feeds / " ( ( Eturauhasen kasvaimet )|( Prostatan kasvaimet )|( Eturauhastuumorit )|( Prostatan syÃ"

Cancers, Vol. 13, Pages 3064: Development and Validation of an Interpretable Artificial Intelligence Model to Predict 10-Year Prostate Cancer Mortality

The impact of the extent of the bone involvement on overall survival and toxicity in mCRPC patients receiving [¹⁷⁷Lu]Lu-PSMA-617: a WARMTH multicentre study

Prostate cancer and the human papilloma virus: causative association, role of vaccines, and the impact of the COVID-19 pandemic

Cells, Vol. 10, Pages 1517: TRIMming Down Hormone-Driven Cancers: The Biological Impact of TRIM Proteins on Tumor Development, Progression and Prognostication

Prostate Imaging Using MRI +/- Contrast Enhancement

Cancers, Vol. 13, Pages 2874: Immune Inflammation Pathways as Therapeutic Targets to Reduce Lethal Prostate Cancer in African American Men

Cancers, Vol. 13, Pages 2944: Response to Androgens and Androgen Receptor Antagonists in the Presence of Cytokines in Prostate Cancer

Cancers, Vol. 13, Pages 2947: Zeb1 and SK3 Channel Are Up-Regulated in Castration-Resistant Prostate Cancer and Promote Neuroendocrine Differentiation

Cancers, Vol. 13, Pages 2965: Glyoxalase-1-Dependent Methylglyoxal Depletion Sustains PD-L1 Expression in Metastatic Prostate Cancer Cells: A Novel Mechanism in Cancer Immunosurveillance Escape and a Potential Novel Target to Overcome PD-L1 Blockade

Cancers, Vol. 13, Pages 2990: Transcriptomic and Genetic Associations between Alzheimer’s Disease, Parkinson’s Disease, and Cancer

The extracellular matrix proteins type I collagen, type III collagen, fibronectin, and laminin 421 stimulate migration of cancer cells

Sequencing Life-Prolonging Agents in Castration-Resistant Prostate Cancer Patients: Comparison of Sequences With and Without 223Ra

Sensors, Vol. 21, Pages 4099: Silver-Assembled Silica Nanoparticles in Lateral Flow Immunoassay for Visual Inspection of Prostate-Specific Antigen

Sensors, Vol. 21, Pages 4099: Silver-Assembled Silica Nanoparticles in Lateral Flow Immunoassay for Visual Inspection of Prostate-Specific Antigen

Antioxidants, Vol. 10, Pages 966: HO-1 Modulates Aerobic Glycolysis through LDH in Prostate Cancer Cells

Integrative genomic and epigenomic analyses identified IRAK1 as a novel target for chronic inflammation-driven prostate tumorigenesis

Diagnostics, Vol. 11, Pages 1087: uPAR PET/CT for Prognostication and Response Assessment in Patients with Metastatic Castration-Resistant Prostate Cancer Undergoing Radium-223 Therapy: A Prospective Phase II Study

Cells, Vol. 10, Pages 1497: Emerging Role and Clinicopathological Significance of AEG-1 in Different Cancer Types: A Concise Review

Cells, Vol. 10, Pages 1497: Emerging Role and Clinicopathological Significance of AEG-1 in Different Cancer Types: A Concise Review

Double-Negative Prostate Cancer Masquerading as a Squamous Cancer of Unknown Primary: A Clinicopathologic and Genomic Sequencing-Based Case Study.

A Proposal to Unify the Classification of Breast and Prostate Cancers Based on the Anatomic Site of Cancer Origin and on Long-term Patient Outcome.

A Proposal to Unify the Classification of Breast and Prostate Cancers Based on the Anatomic Site of Cancer Origin and on Long-term Patient Outcome

Cancers, Vol. 12, Pages 3254: The CHEK2 Variant C.349A>G Is Associated with Prostate Cancer Risk and Carriers Share a Common Ancestor

Cancers, Vol. 12, Pages 3254: The CHEK2 Variant C.349A>G Is Associated with Prostate Cancer Risk and Carriers Share a Common Ancestor

The evolutionary history of lethal metastatic prostate cancer.

BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers.

BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers.

BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers.

BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers.

BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers.

The effect of sample size on polygenic hazard models for prostate cancer.

The effect of sample size on polygenic hazard models for prostate cancer.

The rise of metastatic bone disease in Ireland

The CHEK2 Variant C.349A>G Is Associated with Prostate Cancer Risk and Carriers Share a Common Ancestor.

The <em>CHEK2</em> Variant C.349A&gt;G Is Associated with Prostate Cancer Risk and Carriers Share a Common Ancestor

The effect of sample size on polygenic hazard models for prostate cancer

The Global Burden of Cancer 2013.

Cancer incidence in persons with type 1 diabetes: a five-country study of 9,000 cancers in type 1 diabetic individuals.

Cancer incidence in persons with type 1 diabetes: a five-country study of 9,000 cancers in type 1 diabetic individuals.

Cancers, Vol. 12, Pages 2882: Genomic Instability Signature of Palindromic Non-Coding Somatic Mutations in Bladder Cancer

Cancers, Vol. 12, Pages 2882: Genomic Instability Signature of Palindromic Non-Coding Somatic Mutations in Bladder Cancer

Pre-clinical Research on Bladder Toxicity After Radiotherapy for Pelvic Cancers: State-of-the Art and Challenges

Cancers, Vol. 13, Pages 357: Estimation of the Potentially Avoidable Excess Deaths Associated with Socioeconomic Inequalities in Cancer Survival in Germany

Cancers, Vol. 13, Pages 448: Diagnosis and Treatment of Primary and Secondary Lung Cancers

The Correlation between PSCA Expression and Neuroendocrine Differentiation in Prostate Cancer

The Correlation between PSCA Expression and Neuroendocrine Differentiation in Prostate Cancer

Cancers, Vol. 12, Pages 2854: Prostate Cancer Metastases Are Strongly Inhibited by Agonistic Epha2 Ligands in an Orthotopic Mouse Model

Cancers, Vol. 12, Pages 2854: Prostate Cancer Metastases Are Strongly Inhibited by Agonistic Epha2 Ligands in an Orthotopic Mouse Model